Intratumoral microbiota: a new perspective in cancer initiation, development, and therapy
This review summarizes how intratumoral microbiota influence tumor development and explores their potential as targets for drug delivery and immunotherapy enhancement.
Authors
- Wei Hua (ORCID: https://orcid.org/0000-0002-3061-5749)
- Cui‐Yun Yu (ORCID: https://orcid.org/0000-0002-2076-6228)
- Zhonghui Luo (ORCID: https://orcid.org/0000-0002-7499-9924)
- Xilian Wang (ORCID: https://orcid.org/0000-0003-1335-453X)
- Fangzhen Luo (ORCID: https://orcid.org/0000-0002-9452-0095)
- Huiling Liu (ORCID: https://orcid.org/0000-0003-1423-8282)
Institutions
- Hunan Academy of Traditional Chinese Medicine (CN)
- University of South China (CN)
Publication Details
- Journal
- RSC Pharmaceutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5pm00045a
- Citations
- 2
- Primary Topic
- Cancer Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.47